V012-7933 Screening compound: N-[6-(4-{[4-(dimethylamino)phenyl]methyl}-1,4-diazepan-1-yl)pyridin-3-yl]-3-methylbenzamide

V012-7933 Screening compound: N-[6-(4-{[4-(dimethylamino)phenyl]methyl}-1,4-diazepan-1-yl)pyridin-3-yl]-3-methylbenzamide
V012-7933 Screening compound: N-[6-(4-{[4-(dimethylamino)phenyl]methyl}-1,4-diazepan-1-yl)pyridin-3-yl]-3-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-7933
N-[6-(4-{[4-(dimethylamino)phenyl]methyl}-1,4-diazepan-1-yl)pyridin-3-yl]-3-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-7933

Molecular Formula

C27H33N5O (C27 H33 N5 O)

Compound Name

N-[6-(4-{[4-(dimethylamino)phenyl]methyl}-1,4-diazepan-1-yl)pyridin-3-yl]-3-methylbenzamide

IUPAC name

N-[6-(4-{[4-(dimethylamino)phenyl]methyl}-14-diazepan-1-yl)pyridin-3-yl]-3-methylbenzamide

SMILES

Cc1cccc(C(Nc(cc2)cnc2N2CCN(Cc(cc3)ccc3N(C)C)CCC2)=O)c1

InChI

InChI=1S/C27H33N5O/c1-21-6-4-7-23(18-21)27(33)29-24-10-13-26(28-19-24)32-15-5-14-31(16-17-32)20-22-8-11-25(12-9-22)30(2)3/h4,6-13,18-19H,5,14-17,20H2,1-3H3,(H,29,33)

InChI Key

XRISWIFPFMOHRA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19912246

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

443.59

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.931

Distribution Coefficient, logD

4.767

Water Solubility, LogSw

-4.46

Polar Surface Area

42.059

Acid Dissociation Constant (pKa)

10.08

Base Dissociation Constant (pKb)

7.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

33.30

V012-7933 in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Proline Kinase Library (2105 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Cancer
  • Digestive system
  • Nervous system
  • Male
  • Female
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases
  • Proteases

References: we are preparing a list of scientific research reports with V012-7933 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-7933?
Check Price and Availability of V012-7933, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-7933 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-7933
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-7933
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-7933 available by request